Abstract:

[Purposes] This study aims to analyze the characteristics of selected F5000 pharmaceutical papers and provide guidance for the high-quality development of Chinese pharmaceutical journals. [Methods] Pharmaceutical papers included in the F5000 platform from 2018 to 2022 were collected, and information such as cited frequency, download frequency, Chinese library classification number, source of research institutions, and funding status was obtained through CNKI. Excel 2010 software was used to statistically analyze the data. [Findings] A total of 542 F5000 pharmaceutical papers are obtained from 15 journals, with a median of 1400.50 downloads and 54.50 citations, respectively. The selected papers come from universities and research institutes of traditional Chinese medicine in major regions such as Beijing, Jiangsu, and Tianjin, and the download and cited frequencies of papers from research institutes of traditional Chinese medicine are relatively high. There are a large number of papers included in disciplines such as traditional Chinese medicine pharmacology, traditional Chinese medicine chemistry, and pharmacology. The download and cited frequencies of papers in disciplines such as traditional Chinese medicine chemistry, pharmaceutical organization, and traditional Chinese medicine pharmaceutical organization are relatively high. The vast majority of papers （469） have received funding at different levels. There are 18 authors with a publication volume of more than two articles, and their papers are published in relatively fixed journals. Among them, six authors have neither master's or doctoral degrees nor associate or senior professional titles. [Conclusions] Pharmaceutical journals should attach importance to basic research, methods, and review papers on traditional Chinese medicine and increase the proportion of editorial board members and young editorial board members in high-level paper production areas such as Beijing and Jiangsu. They should also establish a long-term awareness of talent cultivation and grow together with outstanding young scholars.

Key words: Pharmacy, Scientific journal, F5000 paper, Publication feature

摘要：

【目的】 分析入选F5000药学类论文特征，为国内药学类科技期刊的高质量发展指明方向。【方法】 收集2018—2022年F5000平台收录的药学类论文，通过中国知网获取论文的被引频次、下载次数、中图分类号、论文机构来源、基金资助情况等信息，采用Excel 2010软件对数据进行统计分析。【结果】 共获得15种期刊的542篇F5000药学类论文，其下载次数和被引频次的中位数分别为1400.50和54.50。入选论文主要来自北京、江苏、天津等地区的中医药大学和中药研究院，并且中药研究院来源论文的下载次数和被引频次均相对较高；中药药理学、中药化学、药理学等学科方向纳入的论文数量较多，中药化学、药事组织、中药药事组织等学科方向论文的下载次数和被引频次较高；绝大多数论文（469篇）受到不同等级的基金资助；发文量≥2篇的作者有18位，其论文发表期刊相对固定，且有6位为非“双高”（同时具有硕士或博士学位和副高或正高级职称）作者。【结论】 药学类科技期刊应重视中药基础研究以及方法、综述类论文，增加北京、江苏等高水平论文产出地区的编委、青年编委比例；树立长远的人才培养意识，与优秀青年学者共同成长。

关键词: 药学, 科技期刊, F5000论文, 发文特征